Literature DB >> 29790340

α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes.

Lorenzo Biancalana1, Lucinda K Batchelor2, Tiziana Funaioli1, Stefano Zacchini3, Marco Bortoluzzi4, Guido Pampaloni1, Paul J Dyson2, Fabio Marchetti1.   

Abstract

α-Diimines are among the most robust and versatile ligands available in synthetic coordination chemistry, possessing finely tunable steric and electronic properties. A series of novel cationic ruthenium(II) p-cymene complexes bearing simple α-diimine ligands, [(η6- p-cymene)RuCl{κ2 N-(HCNR)2}]NO3 (R = Cy, [1]NO3; R = 4-C6H10OH, [2]NO3; R = 4-C6H4OH, [3]NO3), were prepared in near-quantitative yields as their nitrate salts. [2]NO3 displays high water solubility. The potential of the α-diimine ligand in [3]NO3 as a carrier of bioactive molecules was investigated via esterification reactions with the hydroxyl groups. Thus, the double-functionalized derivatives [(η6- p-cymene)RuCl{κ2 N-(HCN(4-C6H4OCO-R))2}]NO3 (R = aspirinate, [5]NO3; valproate, [6]NO3) and also [4]Cl (R = Me) were obtained in good-to-high yields. UV-vis and multinuclear NMR spectroscopy and cyclic voltammetric studies in aqueous solution revealed only minor ruthenium chloride hydrolytic cleavage, biologically accessible reduction potentials, and pH-dependent behavior of [3]NO3. Density functional theory analysis was performed in order to compare the Ru-Cl bond strength in [1]+ with the analogous ethylenediamine complex, showing that the higher stability observed in the former is related to the electron-withdrawing properties of the α-diimine ligand. In vitro cytotoxicity studies were performed against tumorigenic (A2780 and A2780cisR) and nontumorigenic (HEK-293) cell lines, with the complexes bearing simple α-diimine ligands ranging from inactive to IC50 values in the low micromolar range. The complexes functionalized with bioactive components, i.e., [5]NO3 and [6]NO3, exhibited a marked increase in the cytotoxicity with respect to the precursor [3]NO3.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29790340     DOI: 10.1021/acs.inorgchem.8b00882

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  3 in total

1.  Automated approach for the evaluation of glutathione-S-transferase P1-1 inhibition by organometallic anticancer compounds.

Authors:  Sarah A P Pereira; A Catarina Baptista L; Lorenzo Biancalana; Fabio Marchetti; Paul J Dyson; M Lúcia M F S Saraiva
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

2.  Tethering Carbohydrates to the Vinyliminium Ligand of Antiproliferative Organometallic Diiron Complexes.

Authors:  Silvia Schoch; Dalila Iacopini; Maria Dalla Pozza; Sebastiano Di Pietro; Ilaria Degano; Gilles Gasser; Valeria Di Bussolo; Fabio Marchetti
Journal:  Organometallics       Date:  2022-02-28       Impact factor: 3.876

3.  Ruthenium(II)-Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis.

Authors:  Jakub Cervinka; Alberto Gobbo; Lorenzo Biancalana; Lenka Markova; Vojtech Novohradsky; Massimo Guelfi; Stefano Zacchini; Jana Kasparkova; Viktor Brabec; Fabio Marchetti
Journal:  J Med Chem       Date:  2022-08-01       Impact factor: 8.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.